Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

iSpecimen Network Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03884400

Enrollment

Registered

2019-03-21

Start date

2021-01-01

Completion date

2026-03-01

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Diseases, Cancer, Cardio-Respiratory Distress, Gastro-Intestinal Disorder, Healthy, Nephritis, Neuro-Degenerative Disease, Pregnancy Related, Women's Health: Endometriosis

Keywords

Observational

Brief summary

This protocol seeks to assist biorepositories/biobanks in distributing their stored specimens and data to researchers that will actually utilize them to advance medicine and technology.

Detailed description

iSpecimen has built a partner network comprised of supplying institutions that have ethically acquired human biospecimens and created biorepositories/biobanks to store the specimens and data. Many of these biorepositories have protocols allowing for the collection of their samples but require an additional IRB or ethics review for the distribution of their samples. This protocol establishes a method of such supply sites to allow their specimens to be distributed and used for research via iSpecimen's technology and network of research clients.

Interventions

PROCEDURESpecimens obtained from surgical, phlebotomy or other non-invasive procedure

Biospecimen Collection

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Specimens and/or data from Biorepositories that have enrolled subjects that have provided consent for the specimens and de-identified data to be collected, stored and distributed. * Specimens from biobanks that have collected materials and de-identified data under a waiver of consent * Specimens from a biobank that meet the criteria for non human subject research under the common rule.

Exclusion criteria

* Specimens and/or that have been obtained from subjects without informed consent, nor waiver of consent or that do not meet the criteria for non human subject research under the common rule.

Design outcomes

Primary

Measure	Time frame	Description
Distribution of Biospecimens From Biorepositories/Biobanks for Research Use	15 years	The number of specimens and subjects distributed per disease will be measured and reported.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026